Innovate Biopharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch INNT and buy or sell other stocks, ETFs, and their options commission-free!About INNT
9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs.
CEOBethany L. Sensenig, MBA
CEOBethany L. Sensenig, MBA
Employees—
Employees—
HeadquartersRaleigh, North Carolina
HeadquartersRaleigh, North Carolina
Founded2012
Founded2012
Employees—
Employees—
INNT Key Statistics
Market cap7.20K
Market cap7.20K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume726.90
Average volume726.90
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0005
52 Week high$0.0005
52 Week low—
52 Week low—
Stock Snapshot
The current Innovate Biopharmaceuticals(INNT) stock price is $2.05, with a market capitalization of 7.2K.
On 2026-03-03, Innovate Biopharmaceuticals(INNT) stock opened at —, reached a high of —, and a low of —.
The Innovate Biopharmaceuticals(INNT)'s current trading volume is 0, compared to an average daily volume of 726.9.
People also own
Based on the portfolios of people who own INNT. This list is generated using Robinhood data, and it’s not a recommendation.